HALO - Halozyme Therapeutics Stock Trading

Halozyme Therapeutics Inc.(NASDAQ: HALO) stock trading, description, contact, officers and directors.

About Halozyme Therapeutics Inc.

Not available

Stock Information

Halozyme Therapeutics Inc. Company Name:

HALO Stock Symbol:

NASDAQ Market:

HALO - Halozyme Therapeutics Stock Trading

Get HALO Alerts

News, Short Squeeze, Breakout and More Instantly...

HALO - Halozyme Announces Expansion Of Collaboration And License Agreement With argenx For ENHANZE® Technology

Halozyme Announces Expansion Of Collaboration And License Agreement With argenx For ENHANZE® Technology PR Newswire SAN DIEGO, Oct. 6, 2020 SAN DIEGO , Oct. 6, 2020 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Halozyme ...
HALO - Halozyme Announces Poster Presentation Of Data From Roche's Phase 1b Study Evaluating Atezolizumab For Subcutaneous Administration Utilizing Enhanze® In Non-Small Cell Lung Cancer

SAN DIEGO , Sept. 17, 2020 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that its collaborator, Roche, presented a poster with data from Part 1 of its Phase 1b study (IMscin001) evaluating atezolizumab (Tecentriq ® ) for subcutaneous administ...
HALO - Halozyme Announces Janssen Submission For FDA Approval Of DARZALEX FASPRO(TM) (daratumumab and hyaluronidase-fihj) For The Treatment Of Patients With Light Chain (AL) Amyloidosis

SAN DIEGO , Sept. 10, 2020 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that its collaborator Janssen Biotech, Inc. (Janssen) has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approva...